RxDoctor Payments DataLook up a doctor →

Dennis Ford, MD

Pain Medicine · Cleveland, TNNPI 1063470045

Payments from drug & device makers

$7,373in general payments, 2019–2025

Across 410 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Collegium Pharmaceutical, Inc.$1K
  • Scilex Pharmaceuticals Inc.$503
  • Novo Nordisk$432
  • Medtronic$402
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$385
  • plus $3K from 35 others

What the payments were for

  • Food & beverage$7,373100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,373 in reported general payments places this provider in the 70th percentile of 112 pain medicine providers in Tennessee.

See all pain medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$257,031
Medicare patients
289
Services billed
27,872

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl138$120,484
BotoxOnabotulinumtoxina48$65,404
RelistorMethylnaltrexone Bromide15$38,255
Buprenorphine112$32,876
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen983$27,315
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen916$26,844
Nurtec OdtRimegepant Sulfate13$22,679
LinzessLinaclotide38$19,928
MovantikNaloxegol Oxalate49$18,910
Xtampza ErOxycodone Myristate35$11,986
Gabapentin601$7,736
ZtlidoLidocaine11$6,203
Oxycodone Hcl302$4,757
Tizanidine Hcl285$3,643
Diclofenac Sodium117$3,340

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er$1,227$132,470173 claims
AbbVieBotox, Linzess$1,441$85,33286 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$385$38,25515 claims
Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate$17$33,242129 claims
PfizerNurtec Odt$367$22,67913 claims
Redhill Biopharma Inc.Movantik$25$18,91049 claims
Scilex Pharmaceuticals Inc.Ztlido$503$6,20311 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 112 pain medicine providers in Tennessee.

Other pain medicine in Cleveland

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →